STOCK TITAN

Alaunos Therapeutics, Inc. (TCRT) Net Income by Year

TCRT

Alaunos Therapeutics, Inc. reported a net loss of $4.2M in fiscal year 2025. This represents an increase of 10.8% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Alaunos Therapeutics, Inc. has filed alongside them.

FY2025 annual
Net Income -$4.2M
YoY +10.8%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

TCRT Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Net Income-$4.2M+10.8%-$4.7M0.0%-$4.7M+87.6%-$37.7M+52.1%-$78.8M+1.5%-$80.0M+32.1%-$117.8M-121.8%-$53.1M+2.2%-$54.3M+67.1%-$165.3M-37.6%-$120.1M-277.9%-$31.8M+44.3%-$57.1M+40.6%-$96.1M-50.7%-$63.8M

TCRT Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$952K+9.4%-$1.0M+6.2%N/A-$1.2M-2.8%-$1.1M+6.9%-$1.1M+36.2%N/A-$1.1M+86.7%-$1.1M+87.1%-$1.7M+83.3%N/A-$8.5M+4.2%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Alaunos Therapeutics, Inc. financials

Frequently Asked Questions

What was Alaunos Therapeutics, Inc.'s net income in fiscal year 2025?

Alaunos Therapeutics, Inc. reported a net loss of $4.2M in fiscal year 2025.

How fast is Alaunos Therapeutics, Inc.'s net income growing?

Alaunos Therapeutics, Inc. (TCRT) net income rose by 10.8% year over year, from -$4.7M to -$4.2M in fiscal year 2025.

How has Alaunos Therapeutics, Inc.'s net income changed over the years?

Across the 15 fiscal years this page covers, Alaunos Therapeutics, Inc. (TCRT) net income went from -$63.8M in fiscal year 2011 to -$4.2M in fiscal year 2025.

Alaunos Therapeutics, Inc. (TCRT) reported -$952K in net income in Q2 2026. This represents an increase of 9.4% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Alaunos Therapeutics, Inc. (TCRT) reported on that line in every period on record.